CJC-1295 Without DAC 5mg + IPA 5mg (Ipamorelin) Synergy Blend – High Purity ≥99% | GHRP/GHRH Research Stack – CJC-1295 + Ipamorelin for Sale

CJC-1295 Without DAC 5mg + IPA 5mg (Ipamorelin) is a synergistic research peptide blend combining a modified GHRH analog with a selective GHRP. This stack is designed for growth hormone research where short-acting, pulsatile stimulation without DAC modification is desired.

CJC-1295 Without DAC (Drug Affinity Complex-free) is a tetrasubstituted GHRH (1-29) analog with enhanced enzymatic resistance but no albumin binding. It provides a shorter, more natural pulsatile GH release profile without prolonged half-life extension.

Looking for CJC-1295 without DAC 5mg + Ipamorelin 5mg for sale from a trusted supplier? Shanghai AmbioPharm, Inc. offers a high purity dual peptide blend manufactured under advanced, quality-controlled environments to support modern research applications. This combination is widely studied in biochemical and peptide research due to its complementary properties, making it a valuable compound for scientific and laboratory use.

Our CJC-1295 without DAC + Ipamorelin peptide blend is synthesized using pharmaceutical-grade processes to ensure ≥99% purity, stability, and consistent batch performance. Unlike DAC-modified versions, CJC-1295 without DAC is commonly used in studies requiring shorter activity profiles, while Ipamorelin complements its research potential. Each order includes a Certificate of Analysis (COA), providing full transparency and verification of product quality. With our manufacturing facility in Shanghai and USA-based distribution support, we ensure fast, secure shipping and reliable supply for both small-scale and bulk orders.

Ipamorelin (IPA) is a selective, non-competitive GHRP (Growth Hormone Releasing Peptide) with unique properties. Unlike other GHRPs, Ipamorelin does not significantly increase appetite, cortisol, or prolactin, making it a cleaner research tool for GH stimulation studies.

At Shanghai AmbioPharm, Inc., we supply high-purity CJC-1295 Without DAC (≥99%) and Ipamorelin (≥99%) as a convenient 5mg + 5mg research blend. Each peptide is independently synthesized, purified, and QC-tested in our FDA-inspected Shanghai facility. Available for fast U.S. delivery from our Clearwater, South Carolina warehouse.

Key Product Details – CJC-1295 Without DAC:

• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys

• Modification: No DAC (Drug Affinity Complex) – no albumin binding

• Half-Life (research): 30-60 minutes (short-acting)

• Purity: ≥99% (HPLC)

Key Product Details – Ipamorelin (IPA):

• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (pentapeptide)

• CAS Number: 170851-70-4

• Molecular Formula: C₃₈H₄₉N₉O₅

• Molecular Weight: 711.9 g/mol

• Purity: ≥99% (HPLC)

• Half-Life (research): 2-3 hours

• Unique Property: Minimal appetite, cortisol, or prolactin effects

Blend Specifications:

• Contents: CJC-1295 Without DAC (5mg) + Ipamorelin (5mg) – two separate vials

• Total Peptide: 10mg (5mg + 5mg)

• Form: Lyophilized white powder (individually vialed)

• Storage: -20°C, protected from light, desiccated

• Grade Available: Non-GMP (R&D) and cGMP (clinical preparatory)

Why Choose AmbioPharm for CJC-1295 Without DAC + IPA 5mg + 5mg?

As a global peptide CDMO, AmbioPharm combines scientific expertise with large-scale manufacturing capabilities. Choosing our CJC-1295 without DAC + Ipamorelin 5mg for sale ensures premium quality, trusted sourcing, and dependable delivery tailored to your research needs.

• ✅ FDA-inspected cGMP manufacturing for both peptides

• ✅ Full Certificate of Analysis (COA) for each component

• ✅ HPLC chromatogram and mass spec data included

• ✅ Independently QC-tested before blending

• ✅ Low endotoxin levels (<1 EU/mg)

• ✅ U.S. warehousing – fast domestic shipping from South Carolina

• ✅ Convenient research stack – no need to source separately

Research Applications:

• Pulsatile GH secretion studies (short-acting profile)

• GHRP/GHRH synergy research

• GH/IGF-1 axis modulation without appetite side effects

• Muscle recovery and protein synthesis research

• Sleep architecture and GH pulse studies

• Metabolic and body composition research

Synergy Mechanism:
CJC-1295 Without DAC activates GHRH receptors on pituitary somatotrophs. Ipamorelin acts on the ghrelin receptor (GHS-R1a) via a non-competitive pathway. Together, they produce additive or synergistic GH release without the desensitization or side effect profiles of other GHRPs.

Intended Use: For laboratory research purposes only. Not for human consumption or clinical use without regulatory approval.

Ordering Information:

• Minimum Order Quantity (MOQ): 1 blend pack (5mg+5mg R&D), 10g+ each (cGMP bulk)

• Lead Time: 2-3 weeks (non-GMP), 6-8 weeks (cGMP)

• Shipping: From Clearwater, SC, USA (2-5 days domestic)